Suven Life Sciences Bags 2 Patents From India And Japan, Shares Rise
Suven Life Sciences Ltd. rose after the company bagged two patents from India and Japan for products used for the treatment of certain disorders related to neurodegenerative diseases such as Alzheimer's disease, ADHD, Huntington's disease and Parkinson.
The Indian patent is valid through 2016 while the Japanese patent is valid through 2033, the company said in a filing on the Bombay Stock Exchange.
Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I (first stage of human testing) or Phase-II (group testing).Suven Life Sciences press release
“We are very pleased by the grant of these patents to Suven for our pipeline of molecules inCNS arena that are being developed for cognitive disorders with high unmet medical need withhuge market potential globally”, said Venkat Jasti, chief executive officer of Suven Life Sciences in the release.
With these two additions, Suven now has 19 patents in India and Japan each.
Shares of the drug maker rose as much as 3.6 percent to Rs 195 post announcement.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
